BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22371183)

  • 1. Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients.
    Santamaría C; Muntión S; Rosón B; Blanco B; López-Villar O; Carrancio S; Sánchez-Guijo FM; Díez-Campelo M; Alvarez-Fernández S; Sarasquete ME; de las Rivas J; González M; San Miguel JF; Del Cañizo MC
    Haematologica; 2012 Aug; 97(8):1218-24. PubMed ID: 22371183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
    Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.
    Zhao Y; Wu D; Fei C; Guo J; Gu S; Zhu Y; Xu F; Zhang Z; Wu L; Li X; Chang C
    Haematologica; 2015 Feb; 100(2):194-204. PubMed ID: 25361944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dicer and Drosha expression in patients with nephrotic syndrome.
    Hejazian SM; Rahbar Saadat Y; Bahmanpour Z; Hosseiniyan Khatibi SM; Ardalan M; Zununi Vahed S
    Biofactors; 2020 Jul; 46(4):645-652. PubMed ID: 32412691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
    Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
    Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Effect of 3'-UTR Variants in
    Bug DS; Tishkov AV; Moiseev IS; Petukhova NV
    Curr Issues Mol Biol; 2021 Jul; 43(2):605-617. PubMed ID: 34287278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.
    Guo X; Liao Q; Chen P; Li X; Xiong W; Ma J; Li X; Luo Z; Tang H; Deng M; Zheng Y; Wang R; Zhang W; Li G
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):49-56. PubMed ID: 21953080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia.
    Raaijmakers MH; Mukherjee S; Guo S; Zhang S; Kobayashi T; Schoonmaker JA; Ebert BL; Al-Shahrour F; Hasserjian RP; Scadden EO; Aung Z; Matza M; Merkenschlager M; Lin C; Rommens JM; Scadden DT
    Nature; 2010 Apr; 464(7290):852-7. PubMed ID: 20305640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.
    Prodromaki E; Korpetinou A; Giannopoulou E; Vlotinou E; Chatziathanasiadou Μ; Papachristou NI; Scopa CD; Papadaki H; Kalofonos HP; Papachristou DJ
    Cell Oncol (Dordr); 2015 Aug; 38(4):307-17. PubMed ID: 26227789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.
    Czubak K; Lewandowska MA; Klonowska K; Roszkowski K; Kowalewski J; Figlerowicz M; Kozlowski P
    Oncotarget; 2015 Sep; 6(27):23399-416. PubMed ID: 26156018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.
    Sand M; Gambichler T; Skrygan M; Sand D; Scola N; Altmeyer P; Bechara FG
    Cancer Invest; 2010 Jul; 28(6):649-53. PubMed ID: 20210522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients.
    Jafari N; Shaghaghi H; Mahmoodi D; Shirzad Z; Alibeiki F; Bohlooli S; Dogaheh HP
    J Clin Neurosci; 2015 Jan; 22(1):200-3. PubMed ID: 25439752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer.
    Torres A; Torres K; Paszkowski T; Jodłowska-Jędrych B; Radomański T; Książek A; Maciejewski R
    Tumour Biol; 2011 Aug; 32(4):769-76. PubMed ID: 21559780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Clinical Significance of ANXA1 and DICER1 in Myelodysplastic Syndromes.
    Wu W; Wan C; Xie Q; Liang X; Wen J; Liu Z
    J Coll Physicians Surg Pak; 2020 Dec; 30(12):1291-1296. PubMed ID: 33397055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of microRNA processing enzymes Drosha and Dicer in gestational diabetes mellitus.
    Rahimi G; Jafari N; Khodabakhsh M; Shirzad Z; Dogaheh HP
    Gynecol Endocrinol; 2015 Feb; 31(2):156-9. PubMed ID: 25295740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dicer, Drosha, and outcomes in patients with ovarian cancer.
    Merritt WM; Lin YG; Han LY; Kamat AA; Spannuth WA; Schmandt R; Urbauer D; Pennacchio LA; Cheng JF; Nick AM; Deavers MT; Mourad-Zeidan A; Wang H; Mueller P; Lenburg ME; Gray JW; Mok S; Birrer MJ; Lopez-Berestein G; Coleman RL; Bar-Eli M; Sood AK
    N Engl J Med; 2008 Dec; 359(25):2641-50. PubMed ID: 19092150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated expression of dicer and drosha in breast cancer.
    Yan M; Huang HY; Wang T; Wan Y; Cui SD; Liu ZZ; Fan QX
    Pathol Oncol Res; 2012 Apr; 18(2):343-8. PubMed ID: 21898071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.